These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21098552)

  • 1. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Gourlay T; Shedden L
    Perfusion; 2010 Nov; 25(6):427-9; author reply 429-30. PubMed ID: 21098552
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence.
    Raja SG; Berg GA
    J Card Surg; 2007; 22(5):445-55. PubMed ID: 17803591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eComment: Re: The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Bockeria LA; Grigoryants RG
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):99. PubMed ID: 19122158
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
    Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
    Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress.
    Goudeau JJ; Clermont G; Guillery O; Lemaire-Ewing S; Musat A; Vernet M; Vergely C; Guiguet M; Rochette L; Girard C
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):39-45. PubMed ID: 17261962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of fatal fat embolism syndrome following cardiopulmonary bypass.
    Hodge AJ; Dymock RB; Sutherland HD
    J Thorac Cardiovasc Surg; 1976 Aug; 72(2):202-5. PubMed ID: 1085389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
    Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
    Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.